The Institute for Health Metrics and Evaluation (IHME) estimates that high body mass index accounts for more than 160 million disability-adjusted life years globally, while diabetes prevalence continues to rise steadily, reinforcing demand for effective therapies like GLP-1 receptor agonists
Moreover, polyphenols may be ingested to improve cognitive action and overall health, especially in adults and the elderly (533, 534)
Why Multiple GLP-1 Coverage Options Benefit Employers Want a behind-the-scenes look at how brokers are helping employers manage GLP-1 medications - without sacrificing budget or care options
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 digital issues and online access to articles 133,45 per year only 11,12 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
10.1038/nchembio.2238 54 KaushikM.YadavA.UpadhyayA.GuptaA.TiwariP.TripathiM.et al (2025)
